These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1543779)

  • 1. Quality of life improvements in CAPD patients treated with subcutaneously administered erythropoietin for anemia.
    Auer J; Simon G; Stevens J; Griffiths P; Howarth D; Anastassiades E; Gokal R; Oliver D
    Perit Dial Int; 1992; 12(1):40-2. PubMed ID: 1543779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
    Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F
    Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration].
    Zehnder C; Blumberg A
    Schweiz Med Wochenschr; 1990 Feb; 120(7):217-20. PubMed ID: 2309110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin in continuous ambulatory peritoneal dialysis: experience with subcutaneous administration.
    Eisele G; Bailie GR; Clement C; Wong E
    Perit Dial Int; 1992; 12(1):34-6. PubMed ID: 1543777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of recombinant erythropoietin after subcutaneous or intraperitoneal administration to patients on CAPD.
    Icardi A; Paoletti E; Molinelli G
    Adv Perit Dial; 1990; 6():292-5. PubMed ID: 1982830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients.
    Boelaert JR; Schurgers ML; Matthys EG; Belpaire FM; Daneels RF; De Cre MJ; Bogaert MG
    Perit Dial Int; 1989; 9(2):95-8. PubMed ID: 2488207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of the anemia with human recombinant erythropoietin in CAPD patients.
    Miranda B; Selgas R; Riñon C; Fernandez-Zamorano A; Borrego F; Ortuño F; Lopez-Revuelta K; Torre A; Sanchez Sicilia L
    Adv Perit Dial; 1990; 6():296-301. PubMed ID: 1982831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: a long-term study.
    Cheng IK; Cy C; Chan MK; Yu L; Fang GX; Wei D
    Clin Nephrol; 1991 May; 35(5):207-12. PubMed ID: 1855328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stepwise correction of anaemia by subcutaneous administration of human recombinant erythropoietin in patients with chronic renal failure maintained by continuous ambulatory peritoneal dialysis.
    Stevens JM; Auer J; Strong CA; Hughes RT; Oliver DO; Winearls CG; Cotes PM
    Nephrol Dial Transplant; 1991; 6(7):487-94. PubMed ID: 1922910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous epoetin beta in renal anemia: an open multicenter dose titration study of patients on continuous peritoneal dialysis.
    Bárány P; Clyne N; Hylander B; Johansson AC; Simonsen O; Larsson R; Frisenette-Fich C; Svensson B; Helmers C
    Perit Dial Int; 1995; 15(1):54-60. PubMed ID: 7734561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia of chronic renal failure: treatment with erythropoietin.
    Navarro M; Alonso A; Avilla JM; Espinosa L
    Child Nephrol Urol; 1991; 11(3):146-51. PubMed ID: 1777893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One year experience with subcutaneous human erythropoietin in CAPD: correction of renal anemia and increased ultrafiltration.
    Lubrich-Birkner I; Schollmeyer P; Steinhauer HB
    Adv Perit Dial; 1990; 6():302-7. PubMed ID: 1982833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective quality of life assessment in hemodialysis patients at different levels of hemoglobin following use of recombinant human erythropoietin.
    McMahon LP; Dawborn JK
    Am J Nephrol; 1992; 12(3):162-9. PubMed ID: 1415377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human erythropoietin in patients on peritoneal dialysis.
    Bargman J
    Perit Dial Int; 1989; 9(4):245-6. PubMed ID: 2488375
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant human erythropoietin dosage in children undergoing hemodialysis and continuous ambulatory peritoneal dialysis.
    Sieniawska M; Roszkowska-Blaim M
    Pediatr Nephrol; 1997 Oct; 11(5):628-30. PubMed ID: 9323294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dialysis efficiency in continuous ambulatory peritoneal dialysis patients treated with erythropoietin.
    Taylor JE; MacTier RA; Henderson IS; Belch JJ; Stewart WK
    Perit Dial Int; 1992; 12(2):221-6. PubMed ID: 1586685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous r-HuEPO therapy in CAPD patients: dose determination and clinical experience.
    Janicka L; Ksiazek A; Baranowicz I; Bednarek-Skublewska A; Mierzicki P; Ksiazek P
    Int Urol Nephrol; 1998; 30(1):91-7. PubMed ID: 9569119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of erythropoietin in continuous ambulatory peritoneal dialysis patients: comparison between intravenous and intraperitoneal administration.
    Nasu T; Mitui H; Shinohara Y; Hayashida S; Ohtuka H
    Perit Dial Int; 1992; 12(4):373-7. PubMed ID: 1420496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous administration of recombinant human erythropoietin to subjects on continuous ambulatory peritoneal dialysis: an erythrokinetic assessment.
    Hughes RT; Cotes PM; Pippard MJ; Stevens JM; Oliver DO; Winearls CG; Royston JP
    Br J Haematol; 1990 Jun; 75(2):268-73. PubMed ID: 2372513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraperitoneal administration of recombinant human erythropoietin.
    Frenken LA; Struijk DG; Coppens PJ; Tiggeler RG; Krediet RT; Koene RA
    Perit Dial Int; 1992; 12(4):378-83. PubMed ID: 1420497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.